Cubist Systematic Strategies’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-32,565
| Closed | -$334K | – | 2850 |
|
2023
Q2 | $334K | Sell |
32,565
-42,805
| -57% | -$439K | ﹤0.01% | 1523 |
|
2023
Q1 | $763K | Sell |
75,370
-364,784
| -83% | -$3.69M | ﹤0.01% | 1620 |
|
2022
Q4 | $4.4M | Sell |
440,154
-5,256
| -1% | -$52.5K | 0.03% | 771 |
|
2022
Q3 | $4.33M | Buy |
445,410
+304,492
| +216% | +$2.96M | 0.02% | 954 |
|
2022
Q2 | $1.37M | Buy |
+140,918
| New | +$1.37M | 0.01% | 1876 |
|
2022
Q1 | – | Sell |
-2,247
| Closed | -$22K | – | 3878 |
|
2021
Q4 | $22K | Buy |
+2,247
| New | +$22K | ﹤0.01% | 3371 |
|